In this episode of Supply Chain 360, we continue our BANI mini-series — exploring how to lead and build in a world that’s brittle, anxious, nonlinear, and incomprehensible.
For years, resilience was the ultimate goal in supply-chain management. But in today’s constant state of disruption, bouncing back isn’t enough. It’s time to move toward viability — the ability to adapt, evolve, and stay relevant no matter what happens next.
We unpack what “viability” really means for pharma supply chains, why traditional recovery models are falling short, and how the next decade belongs to companies that design for continuous adaptation.
You’ll hear practical insights on how to rethink supply-chain design through the CORE lens — Complexity, Orchestration, Risk, and Enablement — and learn why the future won’t reward the most resilient networks, but the most viable ones.
